According to a recent LinkedIn post from C8 Health, research presented at the #periop2026 meeting links use of the C8 Health system to improved perioperative glucose management at The University of Texas Medical Branch. The post credits clinicians Cameron Holguin, M.D., Robert Martinez, Brian Masel, and Tomer Cramer for leading the prospective study.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The LinkedIn post highlights an approximate 9.1% absolute increase in perioperative glucose management compliance over a three month period at the institution. It further suggests that users of the C8 system achieved roughly a 20% absolute increase in compliance compared with non users.
According to the post, the health system is now projected to recoup more than $700,000 in annual savings from reduced surgical site infections, which is attributed to these compliance gains. The commentary positions this as an example of individualized, data-driven, clinically integrated quality improvement supported by C8’s technology.
For investors, the reported outcomes imply that C8 Health’s platform may deliver measurable operational and cost benefits for hospital clients, potentially strengthening the company’s value proposition in perioperative care and quality improvement. If similar results are replicated at additional sites, the data could support broader adoption, reinforce pricing power, and enhance C8 Health’s competitive position within healthcare IT and analytics.